Fred Hassan is a director with the private equity firm Warburg Pincus and a board member of Amgen, Intrexon, Modernizing Medicine, Theramex and Vertice.
He is the former chairman and CEO of Schering-Plough and of the Pharmacia Corp. Earlier in his career, he spent 17 years with Sandoz Pharmaceuticals (now Novartis), heading its U.S. pharmaceuticals business.
So, when Hassan wants to talk pharmaceuticals, you should listen. And he will be doing just that at noon Tuesday on a free webinar.
Hassan will discuss numerous topics with moderator James Barrood:
- The battle against COVID and the progress on vaccines and treatments;
- The state of innovation in the biotech and pharma industries;
- Forecasts for health care in 2021 and beyond.
There also will be a question-and-answer period.
“Fred Hassan is one of the preeminent pharma industry leaders of our time,” Barrood said. “As the former CEO of Schering-Plough and Pharmacia, Fred brings really smart insights about the industry’s remarkable response to the COVID-19 pandemic and the challenges ahead with vaccine distribution.
“He also has a keen vision into the future — and how he thinks health care will change permanently post-pandemic.”
Hassan’s stature in pharma — and the business world — cannot be overstated.
His 2013 book: “Reinvent — A Leader’s Playbook for Serial Success,” has been discussed at many global organizations, including the World Bank.
In 2014, a CNBC panel named Hassan to a list of those who have had the most profound impact on the world of business in the previous quarter-century.
Hassan received a B.S. in chemical engineering from the Imperial College of Science and Technology at the University of London and an MBA from Harvard Business School.
He has chaired significant pharmaceutical industry organizations, including the Pharmaceutical Research and Manufacturers of America and the International Federation of Pharmaceutical Manufacturers Associations.
Click here to register.
